SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326190-22-000013
Filing Date
2022-11-10
Accepted
2022-11-10 16:13:01
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20220930x10q.htm   iXBRL 10-Q 1337752
2 EX-31.1 alt-20220930xex31d1.htm EX-31.1 11945
3 EX-31.2 alt-20220930xex31d2.htm EX-31.2 11788
4 EX-32.1 alt-20220930xex32d1.htm EX-32.1 6765
5 EX-32.2 alt-20220930xex32d2.htm EX-32.2 6895
6 GRAPHIC alt-20220930x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001326190-22-000013.txt   5452126

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20220930.xsd EX-101.SCH 43356
8 EX-101.CAL alt-20220930_cal.xml EX-101.CAL 42426
9 EX-101.DEF alt-20220930_def.xml EX-101.DEF 149763
10 EX-101.LAB alt-20220930_lab.xml EX-101.LAB 386480
11 EX-101.PRE alt-20220930_pre.xml EX-101.PRE 273396
60 EXTRACTED XBRL INSTANCE DOCUMENT alt-20220930x10q_htm.xml XML 815699
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 221377311
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences